Cresilon Revenue and Competitors

Location

#1947

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Cresilon's estimated annual revenue is currently $14.4M per year.(i)
  • Cresilon's estimated revenue per employee is $155,000
  • Cresilon's total funding is $51.8M.

Employee Data

  • Cresilon has 93 Employees.(i)
  • Cresilon grew their employee count by 63% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com. We are always looking for dynamic people to join our team as we dive into a range of challenges at the forefront of science and technology—to learn more about our openings please visit https://cresilon.workable.com/.

keywords:Medical Devices, Veterinary, Surgical Hemostasis, Emergency Medical Services

$51.8M

Total Funding

93

Number of Employees

$14.4M

Revenue (est)

63%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cresilon's People

NameTitleEmail/Phone
1
Staff AccountantReveal Email/Phone
2
Quality Control MicrobiologistReveal Email/Phone
3
Process Engineer IIReveal Email/Phone
4
R&D Process LeadReveal Email/Phone
5
VP, Quality & Regulatory AffairsReveal Email/Phone
6
Scientist I, Preclinical ResearchReveal Email/Phone
7
EVP, Co-FounderReveal Email/Phone
8
Sales DirectorReveal Email/Phone
9
VP, Technology (Research & Development and Manufacturing Technology)Reveal Email/Phone
10
VP, Business DevelopmentReveal Email/Phone

Cresilon News

2022-04-13 - Hemostasis on Contact: Interview with Joe Landolina, CEO of ...

Cresilon, a New York-based medtech company, specializes in developing hemostatic technology. Its co-founder and CEO, Joe Landolina,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.3M93-32%$47.7M
#2
$3.5M9329%N/A
#3
$7.5M93-6%N/A
#4
$21.1M9312%N/A
#5
$9.4M943%N/A